Two products approved by FDA will be available in 2017.

David Kliff, of the Diabetes Investor newsletter, attempts to explain why the cost of insulin is so high and how to solve the problem.

You have to love it when research studies come out and prove what you believed all along. I had this experience recently when a systematic review and meta-analysis (looking at the results from multiple studies simultaneously) e-published ahead of print in Emergency Medicine Journal in September 2016 (1) compared the speed of glucose tablets against dietary sugars for treating hypoglycemia in adults who had symptoms of being low. The dietary forms of sugar tested included sucrose (table sugar), fructose (fruit sugar), orange juice (containing fructose), jelly beans, Mentos, cornstarch hydrolysate, Skittles, and milk.

This injectable drug class focuses on the incretin system and leads to increased insulin secretion, decreased glucagon secretion, and slowed gastric emptying. One of its advantages is that its use can lead to weight loss: 1. GLP-1 receptor agonists 2. SGLT-2 Inhibitors 3. DPP-IV 4. Sulfonylureas Did you get the right answer? Follow the link to find out!

Do you feel that with our new president, changes to the Affordable Care Act will be: 1. Negative 2. Positive 3. Unsure Follow the link to share your opinion and see what your colleagues think!

Each and every week, we try to bring you the best in diabetes care in our clinical newsletter. However, no matter how much education we give a patient or how great the new drugs are, if a patient can’t afford the medicines they need then they are doomed to failure. …

Laurie Klipfel, RN, MSN, BC-ANP, CDE was recently asked if she could offer any pearls of wisdom for another Disaster Averted regarding a patient with type 1 diabetes who couldn't afford his analog insulin. After reading her advice, keep reading to learn how you can take action to help make insulin more affordable.

Dr. Jeffrey Mechanick talks with Diabetes in Control Publisher Steve Freed at the 2016 AACE Meeting. In part 5 of this Exclusive Interview, Dr. Mechanick explains how he helps patients determine ways to improve their lifestyle.

In this week's Homerun Slides, blood-based glucose sensors vs. subcutaneous CGM sensors.

Secretion of incretin hormones: The mucosa of the intestinal tract harbors a large number of endocrine cells that give rise to various peptide hormones. These include cholecystokinin, motilin, secretin, gastrin, gastric inhibitory polypeptide (GIP, also referred to as glucose-dependent insulinotropic polypeptide), glucagon-like peptide 1 (GLP-1), glucagon-like peptide 2, and peptide YY.